WAS
RIGL icon

Winch Advisory Services’s Rigel Pharmaceuticals RIGL Stock Holding History

Winch Advisory Services’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-30
Closed -$1K – 340
2018
Q2 		$1K Buy
+30
New +$1.07K ﹤0.01% 321

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
OppenheimerFunds
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Winch Advisory Services's RIGL Position: Q3 2018 in Review

Winch Advisory Services sold out of Rigel Pharmaceuticals (RIGL) in Q3 2018, closing a stake of 30 shares — an estimated $1K sold.

Winch Advisory Services first reported a position in RIGL in Q2 2018 and held it in 1 quarter. The position peaked at $1K in Q2 2018. 135 funds tracked by Wall St. Rank hold RIGL as of Q3 2018.

  • Winch Advisory Services reported no remaining Rigel Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Winch Advisory Services sold 30 Rigel Pharmaceuticals shares in Q3 2018, an estimated $1K.
  • Winch Advisory Services first reported a position in Rigel Pharmaceuticals in Q2 2018 and held it in 1 quarter.
  • Winch Advisory Services's Rigel Pharmaceuticals position peaked at $1K in Q2 2018.
  • 135 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2018.

Based on Winch Advisory Services's 13F filing for Q3 2018, filed 13 Nov 2018.